AbCellera Biologics (ABCL) Return on Equity [ROE] (2020 - 2026)
AbCellera Biologics (ABCL) reported Return on Equity [ROE] of -17.95% for Q2 2026, down 1.63 percentage points from -16.32% a year earlier and down 2.84 percentage points from the prior quarter.
Powered by 
Analysis
AbCellera Biologics (ABCL) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, AbCellera Biologics posted Return on Equity [ROE] of -14.47%, up 0.27 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of -42.76 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -14.75% in FY2024 (-2.48 pp), -12.27% in FY2023 (-26.31 pp), 14.03% in FY2022 (-2.50 pp) and 16.53% in FY2021 (-11.75 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] in data going back to Q4 2020.
- Year over year, Return on Equity [ROE] gained in two of the last eight quarters, with an average year-over-year change of -1.96 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q1 2026 (a gain of 1.03 percentage points); the low point was Q3 2023 (a drop of 31.03 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -15.11% (Q1 2026), -15.16% (Q4 2025) and -17.42% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 22.24% |
| 10 | AbCellera Biologics | 4.27 Bn | 4.27 Bn | - | -17.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.95% |
| Mar 31, 2026 | -15.11% |
| Dec 31, 2025 | -15.16% |
| Sep 30, 2025 | -17.42% |
| Jun 30, 2025 | -16.32% |
| Mar 31, 2025 | -16.15% |
| Dec 31, 2024 | -15.26% |
| Sep 30, 2024 | -16.06% |
| Jun 30, 2024 | -13.68% |
| Mar 31, 2024 | -12.87% |
| Dec 31, 2023 | -12.54% |
| Sep 30, 2023 | -10.86% |
| Jun 30, 2023 | -6.15% |
| Mar 31, 2023 | -4.11% |
| Dec 31, 2022 | 12.77% |
| Sep 30, 2022 | 20.17% |
| Jun 30, 2022 | 16.56% |
| Mar 31, 2022 | 18.34% |
| Dec 31, 2021 | 15.51% |
| Sep 30, 2021 | 25.97% |
API Access
AbCellera Biologics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();